Clinical trials
Phase 1/2 Thrombocytopenia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 1 |
| Children's Hospital Los Angeles | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Drexel University College of Medicine | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| M.D. Anderson Cancer Center | 1 |
| Meghan McCormick | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| PrECOG, LLC. | 1 |
| Protalex, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 12 |
| Leukemia | 3 |
| Anemia | 2 |
| Anemia, Aplastic | 2 |
| Anemia, Refractory | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Autoimmune Diseases | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.